MRK
Merck & Co Inc
Price:  
128.19 
USD
Volume:  
5,413,214.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Merck EV/EBITDA

-60.7%
Upside

As of 2024-02-29, the EV/EBITDA ratio of Merck & Co Inc (MRK) is 32.15. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Merck's latest enterprise value is 351,090.03 mil USD. Merck's TTM EBITDA according to its financial statements is 10,919.00 mil USD. Dividing these 2 quantities gives us the above Merck EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 8.7x - 25.1x 16.4x
Forward P/E multiples 13.2x - 24.9x 19.0x
Fair Price 24.79 - 97.71 50.39
Upside -80.7% - -23.8% -60.7%
128.19 USD
Stock Price
50.39 USD
Fair Price

Merck EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-02-28 32.15
2024-02-27 32.35
2024-02-26 32.30
2024-02-23 32.45
2024-02-22 32.40
2024-02-21 32.14
2024-02-20 31.96
2024-02-16 32.06
2024-02-15 31.77
2024-02-14 31.60
2024-02-13 31.51
2024-02-12 31.49
2024-02-09 31.52
2024-02-08 31.79
2024-02-07 31.99
2024-02-06 31.85
2024-02-05 31.69
2024-02-02 31.74
2024-02-01 31.73
2024-01-31 30.43
2024-01-30 30.64
2024-01-29 30.55
2024-01-26 30.44
2024-01-25 30.28
2024-01-24 29.99
2024-01-23 30.22
2024-01-22 30.12
2024-01-19 30.00
2024-01-18 29.91
2024-01-17 29.82
2024-01-16 29.90
2024-01-12 29.94
2024-01-11 29.89
2024-01-10 29.99
2024-01-09 29.89
2024-01-08 29.65
2024-01-05 29.61
2024-01-04 29.56
2024-01-03 29.04
2024-01-02 28.68
2023-12-29 27.71
2023-12-28 27.65
2023-12-27 27.46
2023-12-26 27.38
2023-12-22 27.40
2023-12-21 27.09
2023-12-20 26.86
2023-12-19 27.12
2023-12-18 27.01
2023-12-15 26.80